Disparate SAR Data of Griseofulvin Analogues for the Dermatophytes Trichophyton mentagrophytes, T. rubrum, and MDA-MB-231 Cancer Cells

Mads Holger Rønnest, Marc S. Raab, Simon Anderhub, Sven Boesen, Alwin Krämer, Thomas Ostenfeld Larsen, Mads Hartvig Clausen

Research output: Contribution to journalJournal articleResearchpeer-review

877 Downloads (Pure)

Abstract

Griseofulvin and 53 analogues of this compound have been tested against the pathogenic dermatophytes Trichophyton rubrum and Trichophyton mentagrophytes as well as against the breast cancer cell line MDA-MB-231. The modifications to griseofulvin include the 4, 5, 6, 2', 3', and 4' positions. The SAR of the griseofulvin analogues toward the two fungi followed the same trend with the majority being less active than griseofulvin and none had more than twice the potency of the parent compound. A comparison of the antifungal and the anticancer SAR revealed distinct differences, as the majority of analogues showed increased activity against the cancer cell line MDA-MB-231, highlighted by 2'-benzyloxy-2'-demethoxy-griseofulvin, which showed low activity against both fungi but was among the most potent compounds against MDA-MB-231 cancer cells. Tubulin has been proposed as the target of griseofulvin in both fungal and mammalian cells, but the differences revealed by this SAR study strongly suggest that the mode-of-action of the compound class toward fungi and mammalian cancer cells is different.
Original languageEnglish
JournalJournal of Medicinal Chemistry
Volume55
Issue number2
Pages (from-to)652-660
ISSN0022-2623
DOIs
Publication statusPublished - 2012

Fingerprint

Dive into the research topics of 'Disparate SAR Data of Griseofulvin Analogues for the Dermatophytes Trichophyton mentagrophytes, T. rubrum, and MDA-MB-231 Cancer Cells'. Together they form a unique fingerprint.

Cite this